Experts recommend against calcitonin-salmon for postmenopausal osteoporosis
Gespeichert in:
| Veröffentlicht in: | American journal of health-system pharmacy 2013-04, Vol.70 (8), p.648, 650-650 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 650 |
|---|---|
| container_issue | 8 |
| container_start_page | 648, 650 |
| container_title | American journal of health-system pharmacy |
| container_volume | 70 |
| creator | Traynor, Kate |
| description | |
| doi_str_mv | 10.2146/news130028 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1324383993</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A330005581</galeid><sourcerecordid>A330005581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-1c99b29cd3fdd328add5ea07221ae5541aa0cf0b64ebcc50ec9f50f748ca26bc3</originalsourceid><addsrcrecordid>eNptkd9LwzAQx4Mobk5f_AOk4IsInZek2drHMeYPHPiizyVNLyPSJjVpUf97MzYVQe7hfvC54-6-hJxTmDKazW4svgfKAVh-QMZUcJGyAuAwxjAvUgY5G5GTEF4BKMthdkxGjAvBgOdj8rj66ND3IfGoXNuirRO5kcaGPlGyUaZ31tg0yKZ1NtHOJ50LfcRcJ4dYTWKGrnPeBRNOyZGWTcCzvZ-Ql9vV8_I-XT_dPSwX61RxkfUpVUVRsULVXNc1Z7msa4ES5oxRiUJkVEpQGqpZhpVSAlAVWoCeZ7mSbFYpPiFXu7mdd28Dhr5sTVDYNNKiG0JJOct4zouCR_Ryh25kg6Wx2vVeqi1eLnh8GQiR00hN_6Gi1dga5SxqE-t_Gq53DSoeHjzqsvOmlf6zpFBuNSl_NYnwxX7doWqx_kG_ReBfw42IJg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1324383993</pqid></control><display><type>article</type><title>Experts recommend against calcitonin-salmon for postmenopausal osteoporosis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Traynor, Kate</creator><creatorcontrib>Traynor, Kate</creatorcontrib><identifier>ISSN: 1079-2082</identifier><identifier>EISSN: 1535-2900</identifier><identifier>DOI: 10.2146/news130028</identifier><identifier>PMID: 23552038</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Bone Density Conservation Agents - adverse effects ; Calcitonin ; Calcitonin - adverse effects ; Care and treatment ; Complications and side effects ; Contraindications ; Dosage and administration ; Drug Approval ; Female ; Health aspects ; Humans ; Male ; Neoplasms - chemically induced ; Osteoporosis ; Osteoporosis, Postmenopausal - drug therapy ; Postmenopausal women ; Safety and security measures</subject><ispartof>American journal of health-system pharmacy, 2013-04, Vol.70 (8), p.648, 650-650</ispartof><rights>COPYRIGHT 2013 Oxford University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-1c99b29cd3fdd328add5ea07221ae5541aa0cf0b64ebcc50ec9f50f748ca26bc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23552038$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Traynor, Kate</creatorcontrib><title>Experts recommend against calcitonin-salmon for postmenopausal osteoporosis</title><title>American journal of health-system pharmacy</title><addtitle>Am J Health Syst Pharm</addtitle><subject>Bone Density Conservation Agents - adverse effects</subject><subject>Calcitonin</subject><subject>Calcitonin - adverse effects</subject><subject>Care and treatment</subject><subject>Complications and side effects</subject><subject>Contraindications</subject><subject>Dosage and administration</subject><subject>Drug Approval</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasms - chemically induced</subject><subject>Osteoporosis</subject><subject>Osteoporosis, Postmenopausal - drug therapy</subject><subject>Postmenopausal women</subject><subject>Safety and security measures</subject><issn>1079-2082</issn><issn>1535-2900</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkd9LwzAQx4Mobk5f_AOk4IsInZek2drHMeYPHPiizyVNLyPSJjVpUf97MzYVQe7hfvC54-6-hJxTmDKazW4svgfKAVh-QMZUcJGyAuAwxjAvUgY5G5GTEF4BKMthdkxGjAvBgOdj8rj66ND3IfGoXNuirRO5kcaGPlGyUaZ31tg0yKZ1NtHOJ50LfcRcJ4dYTWKGrnPeBRNOyZGWTcCzvZ-Ql9vV8_I-XT_dPSwX61RxkfUpVUVRsULVXNc1Z7msa4ES5oxRiUJkVEpQGqpZhpVSAlAVWoCeZ7mSbFYpPiFXu7mdd28Dhr5sTVDYNNKiG0JJOct4zouCR_Ryh25kg6Wx2vVeqi1eLnh8GQiR00hN_6Gi1dga5SxqE-t_Gq53DSoeHjzqsvOmlf6zpFBuNSl_NYnwxX7doWqx_kG_ReBfw42IJg</recordid><startdate>20130415</startdate><enddate>20130415</enddate><creator>Traynor, Kate</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130415</creationdate><title>Experts recommend against calcitonin-salmon for postmenopausal osteoporosis</title><author>Traynor, Kate</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-1c99b29cd3fdd328add5ea07221ae5541aa0cf0b64ebcc50ec9f50f748ca26bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Bone Density Conservation Agents - adverse effects</topic><topic>Calcitonin</topic><topic>Calcitonin - adverse effects</topic><topic>Care and treatment</topic><topic>Complications and side effects</topic><topic>Contraindications</topic><topic>Dosage and administration</topic><topic>Drug Approval</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasms - chemically induced</topic><topic>Osteoporosis</topic><topic>Osteoporosis, Postmenopausal - drug therapy</topic><topic>Postmenopausal women</topic><topic>Safety and security measures</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Traynor, Kate</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of health-system pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Traynor, Kate</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experts recommend against calcitonin-salmon for postmenopausal osteoporosis</atitle><jtitle>American journal of health-system pharmacy</jtitle><addtitle>Am J Health Syst Pharm</addtitle><date>2013-04-15</date><risdate>2013</risdate><volume>70</volume><issue>8</issue><spage>648, 650</spage><epage>650</epage><pages>648, 650-650</pages><issn>1079-2082</issn><eissn>1535-2900</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>23552038</pmid><doi>10.2146/news130028</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1079-2082 |
| ispartof | American journal of health-system pharmacy, 2013-04, Vol.70 (8), p.648, 650-650 |
| issn | 1079-2082 1535-2900 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1324383993 |
| source | MEDLINE; Journals@Ovid Complete; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Bone Density Conservation Agents - adverse effects Calcitonin Calcitonin - adverse effects Care and treatment Complications and side effects Contraindications Dosage and administration Drug Approval Female Health aspects Humans Male Neoplasms - chemically induced Osteoporosis Osteoporosis, Postmenopausal - drug therapy Postmenopausal women Safety and security measures |
| title | Experts recommend against calcitonin-salmon for postmenopausal osteoporosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A36%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experts%20recommend%20against%20calcitonin-salmon%20for%20postmenopausal%20osteoporosis&rft.jtitle=American%20journal%20of%20health-system%20pharmacy&rft.au=Traynor,%20Kate&rft.date=2013-04-15&rft.volume=70&rft.issue=8&rft.spage=648,%20650&rft.epage=650&rft.pages=648,%20650-650&rft.issn=1079-2082&rft.eissn=1535-2900&rft_id=info:doi/10.2146/news130028&rft_dat=%3Cgale_proqu%3EA330005581%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1324383993&rft_id=info:pmid/23552038&rft_galeid=A330005581&rfr_iscdi=true |